Lexaria Bioscience Corp Asset Turnover Ratio (LEXX), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lexaria Bioscience Corp   (NASDAQ: LEXX)
 

Lexaria Bioscience Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet May 31 2026, Lexaria Bioscience Corp has not recorded any assets.
Visit Lexaria Bioscience Corp Balance sheet

Within sector Lexaria Bioscience Corp achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LEXX Asset Turnover Ratio (May 31 2026)
III. Quarter		 (Feb 28 2026)
II. Quarter		 (Nov 30 2025)
I. Quarter		 (Aug 31 2025)
IV. Quarter		 (May 31 2025)
III. Quarter
Y / Y Asset Change -28.43 % -25.06 % -52.54 % -52.54 % -32.07 %
Y / Y Revenue Change - -88.51 % - 107.14 % 107.14 %
Asset Turnover Ratio (TTM) - 0.07 - 0.1 0.07
LEXX's Total Ranking # # # # #
Seq. Asset Change -25.66 % 54.54 % 0 % -37.71 % -22.15 %
Seq. Revenue Change - - - 0 % 0 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




LEXX Company Profile • Back to LEXX Efficiency Comparisons • Compare LEXX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending May 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending May 31 2026 Assets at quarter ending May 31 2026
Surrozen Inc   0.11 $ 11.511  Millions$ 107.272  Millions
C4 Therapeutics Inc   0.11 $ 35.039  Millions$ 328.207  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Ginkgo Bioworks Holdings Inc   0.10 $ 111.863  Millions$ 1,082.996  Millions
Zymeworks Inc   0.09 $ 37.127  Millions$ 404.744  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Bolt Biotherapeutics Inc   0.09 $ 4.700  Millions$ 52.543  Millions
Bicycle Therapeutics Plc  0.09 $ 61.205  Millions$ 685.131  Millions
Therapeuticsmd Inc   0.09 $ 3.270  Millions$ 37.859  Millions
Lenz Therapeutics Inc   0.08 $ 21.475  Millions$ 256.428  Millions
Ocular Therapeutix Inc   0.08 $ 52.054  Millions$ 655.696  Millions
Agios Pharmaceuticals Inc   0.08 $ 98.338  Millions$ 1,244.086  Millions
Astrotech Corp  0.08 $ 1.701  Millions$ 21.727  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Longeveron Inc   0.08 $ 1.187  Millions$ 15.629  Millions
Armata Pharmaceuticals Inc   0.07 $ 6.034  Millions$ 81.537  Millions
Stablecoin Development Corporation  0.07 $ 5.627  Millions$ 79.945  Millions
Intellia Therapeutics Inc   0.07 $ 59.506  Millions$ 845.836  Millions
Cytomx Therapeutics Inc   0.07 $ 18.302  Millions$ 262.601  Millions
Stoke Therapeutics Inc   0.07 $ 27.588  Millions$ 403.985  Millions
Kymera Therapeutics Inc   0.07 $ 105.000  Millions$ 1,539.829  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Ocugen Inc   0.06 $ 4.580  Millions$ 70.556  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
EBR Systems, Inc.  0.06 $ 6.446  Millions$ 105.295  Millions
Caribou Biosciences Inc   0.06 $ 10.035  Millions$ 165.531  Millions
Grail Inc   0.06 $ 165.263  Millions$ 2,792.551  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Nexalin Technology Inc   0.05 $ 0.217  Millions$ 4.115  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.